Chen Katz

Chen Katz is a highly motivated scientist with extensive experience in cancer biology, immuno-oncology, and molecular biology. Currently serving as the Principal Scientist in Virology at Antylia Scientific, Chen has previously held leadership roles at Kineta and Columbia University, focusing on the preclinical development of immuno-oncology drugs and the p53 protein's implications in cancer. With over ten years of project management and research experience, Chen has contributed significantly to scientific literature and has mentored numerous junior scientists. Their academic journey includes a Ph.D. in Chemical Biology from The Hebrew University of Jerusalem and postdoctoral research at Columbia University.